Nuzenio

Roivant

Roivant news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 12:25:35 GMTRoivant Sciences shifts to commercial biopharma with $4.7B cash, eyeing FDA approval for brepocitinib by 2026 - Pluang
Sat, 08 Aug 2026 06:38:12 GMTRoivant Sciences (ROIV) Stock Rally Leans On Cash As Losses Persist - simplywall.st
Fri, 07 Aug 2026 16:14:46 GMTsymbol__ Stock Quote Price and Forecast - CNN
Fri, 07 Aug 2026 12:30:00 GMTRoivant Sciences Ltd. Q1 2026 Earnings Call Summary - Yahoo Finance
Fri, 07 Aug 2026 11:03:57 GMTRoivant Sciences Q1 Earnings Call Highlights - Yahoo Finance
Thu, 06 Aug 2026 23:20:30 GMTRoivant Sciences Ltd. Stock 12‑Month Price Target Raised to $39.73, Implies 15% Upside - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Roivant.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.